Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Ningying Wu"'
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Externí odkaz:
https://doaj.org/article/a3225709a83e4c7eb5053dc492c8d853
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
PurposeTo identify modifiable risk factors associated with prolonged clearance of methotrexate in pediatric, adolescent, and young adult (AYA) oncology patients receiving high dose methotrexate (HDMTX).Design/MethodA single institution, retrospective
Externí odkaz:
https://doaj.org/article/d26f6929c9b945829050193c78c2f2e6
Autor:
Farrokh Dehdashti, Ningying Wu, Cynthia X. Ma, Michael J. Naughton, John A. Katzenellenbogen, Barry A. Siegel
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-9 (2021)
Clinical estrogen receptor (ER) testing for breast cancer is limited in predicting response to endocrine therapy (ET). In this phase 2 clinical trial, authors demonstrate that the responsiveness to ET can be predicted by use of PET/CT with 21-[18F]fl
Externí odkaz:
https://doaj.org/article/ff6d3e01875a44a08508cf739b64d668
Autor:
Miranda L. Camet, Anne Spence, Susan S. Hayashi, Ningying Wu, Jennifer Henry, Kara Sauerburger, Robert J. Hayashi
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundSensorineural hearing loss is a well-known side effect of cisplatin (CDDP). There is limited research on the effect of dosing, infusion times, and schedules of cisplatin administration and their impact on hearing loss.MethodsA retrospective
Externí odkaz:
https://doaj.org/article/92e6593ef685457c93bc217c61cbee33
Publikováno v:
Frontiers in Oncology; 2023, p1-9, 9p
Autor:
Linh, Vuong, Su-Hsin, Chang, Fei, Wan, Ningying, Wu, J Chris, Eagon, Shaina R, Eckhouse, Francesca M, Dimou
Publikováno v:
Journal of the American College of Surgeons. 235:186-194
In the US, obesity continues to be a severe health issue now affecting adolescents. Bariatric surgery remains the most effective treatment for obesity, but use among adolescents remains low. The objective of this study was to identify current nationa
Autor:
Graham A. Colditz, Debbie L. Bennett, Jennifer Tappenden, Courtney Beers, Nicole Ackermann, Ningying Wu, Jingqin Luo, Sarah Humble, Erin Linnenbringer, Kia Davis, Shu Jiang, Adetunji T. Toriola
Publikováno v:
Cancer Causes & Control. 33:623-629
PurposeThe Joanne Knight Breast Health Cohort was established to link breast cancer risk factors, mammographic breast density, benign breast biopsies and associated tissue markers, and blood markers in a diverse population of women undergoing routine
Autor:
Mateusz Opyrchal, Kian-Huat Lim, Jace Webster, Saiama N. Waqar, Albert C. Lockhart, Ningying Wu, Christopher G. Maher, Nick Boice, Joel Picus, Andrea Wang-Gillam, Benjamin R. Tan, Feng Gao, Maria Q. Baggstrom, Abhi Acharya, Daniel Morgensztern, Ramaswamy Govindan
Publikováno v:
European Journal of Cancer. 154:102-110
Aim Aurora kinase A (AURKA) is a pleiotropic serine/threonine kinase that orchestrates mitotic progression. Paclitaxel stabilises microtubules and disrupts mitotic spindle assembly. The combination of AURKA inhibitor (alisertib) plus paclitaxel may b
Autor:
Peter Oppelt, Haeseong Park, Ningying Wu, Siddhartha Devarakonda, Saiama N. Waqar, Maria Q. Baggstrom, Ramaswamy Govindan, Rama Suresh, Daniel Morgensztern, Luke Verghese, Bruna Pellini
Publikováno v:
Journal of Thoracic Disease. 13:4054-4062
Background Activation of the mTOR pathway has been implicated in the development of several malignancies and alterations in TSC1, TSC2, STK11 and NF1, can lead to the dysregulation of this pathway. Furthermore, mutations in TSC1 and NF2 are known to
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 40(11)